Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab
2018
Key Points Cold agglutinin syndrome is one of the rare immune-related adverse events of nivolumab. Rituximab should be considered for treatment of nivolumab-induced cold agglutinin syndrome.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
16
References
10
Citations
NaN
KQI